News and Views

Treatment Side Effects

Oncology Dietitians Tackle Nutritional Barriers and Dispel Misinformation

Because they often face nutrition challenges—such as nausea, taste alterations, difficulty swallowing, and altered gastrointestinal function—that develop during their journey and hinder their nutrition stability, patients with cancer have increased nutrient needs. Oncology dietitians are experts at guiding patients and caregivers through the nutritional process and developing solutions.

Trending Topics

View All Topics

Food for Thought: Prevent and Screen for Malnutrition in Patients with Cancer

Clinical Practice

Food for Thought: Prevent and Screen for Malnutrition in Patients With Cancer

Nurses Are the Key to Achieving Health Equity

Nurses Are the Key to Achieving Health Equity

FDA Approves Asparaginase Erwinia Chrysanthemi for Leukemia and Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn for Leukemia and Lymphoma

Strong Social Relationships Strengthen and Sustain You

Nurse Well-Being

Strong Social Relationships Strengthen and Sustain You

Immunotherapy Extends Survival in Uveal Melanoma

Immunotherapy Extends Survival in Uveal Melanoma

Oncology Drug Reference Sheet: Tepotinib

Drug Reference Sheets

Oncology Drug Reference Sheet: Tepotinib

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

U.S. Food and Drug Administration (FDA)

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

Single-Chain Diabodies May Target Variants in Both Solid and Liquid Tumors

Cancer Research

Single-Chain Diabodies May Target Variants in Both Solid and Liquid Tumors

Conflict Engagement Helps Providers Focus on Care

Clinical Practice

Conflict Engagement Helps Providers Focus on Care

When Grief Goes Beyond Burnout, Organizations Must Intervene

Grief & Bereavement

When Grief Goes Beyond Burnout, Organizations Must Intervene

APRNs Are Essential in Survivorship Programs

Survivorship Care Plans

APRNs Are Essential in Survivorship Programs

Racial Minorities Receive More Aggressive EOL Ovarian Cancer Care

Racial Minorities Receive More Aggressive EOL Ovarian Cancer Care

Research Findings Confirm Link Between Communication and Safety

Research Findings Confirm Link Between Communication and Safety

Managing COVID-19 and Cancer Requires Enhanced Palliative Care Skills

Managing COVID-19 and Cancer Requires Enhanced Palliative Care Skills

Congratulations to ONS Director-at-Large Valerie Burger, RN, MA, MS, OCN®, CPN, whom the ONS Board of Directors selected as treasurer, and ONS Director-at-Large Darcy Burbage, DNP, RN, AOCN®, CBCN®, whom it selected as secretary, during its April 13, 2021, meeting.

ONS Board of Directors

Board Appoints Officers, Doubles Chapter Visits, Updates Navigator Position, and More

Nursing Considerations for Prostate Cancer Survivorship Care

Clinical Practice

Nursing Considerations for Prostate Cancer Survivorship Care

Multimethod Approach Supports Providers’ Mental Health During COVID-19

Multimethod Approach Supports Providers’ Mental Health During COVID-19

On May 28, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to infigratinib (Truseltiq™), a kinase inhibitor for patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test. FDA also approved the FoundationOne® CDx as a companion diagnostic for infigratinib.

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma

Maximize Your Words’ Healing Power

Clinical Practice

Maximize Your Words’ Healing Power

On May 28, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to sotorasib (Lumakras™), a RAS GTPase family inhibitor, for adult patients with KRAS G12Cmutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA approved test, who have received at least one prior systemic therapy.

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Sotorasib for KRAS G12C-Mutated NSCLC

On May 27, 2021, the U.S. Food and Drug Administration (FDA) approved piflufolastat F 18 (Pylarify®), a drug for positron-emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in patients with prostate cancer.

U.S. Food and Drug Administration (FDA)

FDA Approves Second PSMA-Targeted PET Imaging Drug for Prostate Cancer

ONS Center for Innovation Launches New Tool to Improve Nurses' Professional Development

ONS Center for Innovation Launches New Tool to Improve Nurses' Professional Development

Imaging Test Identifies Treatment Choices for ER-Positive Breast Cancer

Imaging Test Identifies Treatment Choices for ER-Positive Breast Cancer

Survey Results Support Predicted Effects of Pandemic Screening Drop

Cancer Screening

Survey Results Support Predicted Effects of Pandemic Screening Drop

Oncology Drug Reference Sheet: Trilaciclib

Clinical Practice

Oncology Drug Reference Sheet: Trilaciclib

Find Your Voice With ONS’s Leadership Development Committee

Find Your Voice With ONS’s Leadership Development Committee

FDA Grants Accelerated Approval to Amivantamab-Vmjw for Metastatic NSCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Amivantamab-Vmjw for Metastatic NSCLC

What the Evidence Says For Dance/Movement Therapy in Cancer Care

Clinical Practice

What the Evidence Says About Dance/Movement Therapy in Cancer Care

FDA Approves Nivolumab for Resected Esophageal or GEJ Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab for Resected Esophageal or GEJ Cancer

Text Messaging Reduces Disparities in Colorectal Cancer Screening

Text Messaging Reduces Disparities in Colorectal Cancer Screening

The Case of the Weight Loss Wishes

Clinical Practice

The Case of the Weight Loss Wishes

Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer

Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer

Electroacupuncture and Auricular Acupuncture for Chronic Musculoskeletal Pain in Cancer Survivors

Pain Management

Electroacupuncture and Auricular Acupuncture for Chronic Musculoskeletal Pain in Cancer Survivors

Nursing Considerations for Melanoma Survivorship Care

Nursing Considerations for Melanoma Survivorship Care

Targeted Therapy Drug Shows Promise in CLL

Targeted Therapy Drug Shows Promise in CLL

Larotrectinib and Other Tumor-Agnostic Targeted Therapies Are Leading Cancer Care Into the Next Frontier

Targeted Therapy

Larotrectinib and Other Tumor-Agnostic Targeted Therapies Are Leading Cancer Care Into the Next Frontier

Evidence-Based Leadership Trends Show How Every Nurse Is a Leader

Evidence-Based Leadership Trends Show How Every Nurse Is a Leader

Oncology Nursing Society Collaborates With Four Organizations to Develop Grief Resources

ONS Collaborates With Four Organizations to Develop Grief Resources

Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers

Clinical Practice

Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers

FDA Grants Accelerated Approval to Pembrolizumab for HER2-Positive Gastric Cancer

Clinical Practice

FDA Grants Accelerated Approval to Pembrolizumab for HER2-Positive Gastric Cancer

Genomics Test Guides Treatment Decisions for Prostate Cancer

Genetics & Genomics

Genomics Test Guides Treatment Decisions for Prostate Cancer

Nursing Leadership Has Space for You and Your Goals

Nursing Professional Development

Nursing Leadership Has Space for You and Your Goals

We Have So Much to Celebrate in Nursing and Cancer Science This Year

We Have So Much to Celebrate in Nursing and Cancer Science This Year

Time in Nature Is Time Well Spent

Nurse Well-Being

Time in Nature Is Time Well Spent

Gut Microbiome May Be a Factor With Immunotherapy Resistance in Advanced Melanoma

Gut Microbiome May Be a Factor With Immunotherapy Resistance in Advanced Melanoma

Oncology Drug Reference Sheet: Relugolix

Clinical Practice

Oncology Drug Reference Sheet: Relugolix

What Oncology Nurses Need to Know About Telehealth

Nurse Empowerment

What Oncology Nurses Need to Know About Telehealth

FDA Grants Accelerated Approval to Loncastuximab Tesirine-Lpyl for Large B-Cell Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Loncastuximab Tesirine-Lpyl for Large B-Cell Lymphoma

Oncology Nurses Receive Awards at the 46th Annual ONS Congress

Oncology Nurses Receive Awards at the 46th Annual ONS Congress

Back to Top ▲